Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2023-02-10
Buyer: SYKEHUSINNKJØP HF
Country: NO
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33600000: Pharmaceutical products
Estimated value: 12180600 NOK
Award criteria: Lowest price

Technical requirements: Voluntary ex ante transparency notice - Additional agreement for LIS 2301d Heparin injection, without preservation, ATC code B01AB01
Sykehusinnkjøp HF, Divisjon legemidler (henceforth referred to as SHI) is collecting tenders for medicines that are used by the health authorities. SHI has previously announced and implemented an open tender contest for unregistered pharmaceuticals 2301d). The tender contest applied to products in accordance with the tender documentation, Annex 03 - the Price sheet.
No agreements were signed for the delivery of Heparin injection, without preservation, ATC code B01AB01 We still need to enter into an agreement.
Sykehusinnkjøp HF, Divisjon legemidler (henceforth referred to as SHI) is collecting tenders for medicines that are used by the health authorities. SHI has previously announced and implemented an open tender contest for unregistered pharmaceuticals 2301d). The tender contest applied to products in accordance with the tender documentation, Annex 03 - the Price sheet.
No agreements were signed for the delivery of Heparin injection, without preservation, ATC code B01AB01 We still need to enter into an agreement.
Based on this, SHI intends to enter into agreements between the regional health trusts (the Contracting Authorities) and Life Medical (the Supplier) as an additional contract to 2301d. I.e. the scope and length of the contract will be in accorcance with the mentioned procurement (including access to extensions and denunciation), without a new tender contest being held for this ingredient. The health trusts that are under the regional health authorities have options to join the contracts. The same applies for non-profit institutions/hospitals with an operational contract with each health region.
SHI has explored the market situation and is of the opinion that it is impossible to hold a new contest, or that a supplier other than Life Medical is able to deliver the product in the impending agreement period, and that the situation that has occurred is not the contracting authorities' fault, nor something that the contracting authorities could predict. SHI therefore believes that there are grounds to make the procurement without an invitation to tender. See the public procurement regulations §21-5, c.f. § 21-2, c.f. § 13-4 letter b no. 3 and letter cf. also § 13-3 letter e.
SHI requests that any objections to this contract award are submitted before the expiry of the waiting period, set to 10 days after the publication of the Voluntary ex ante transparency notice. If no objections are received, contracts will be signed after the waiting period has expired.
SHI has explored the market situation and is of the opinion that it is impossible to hold a new contest, or that a supplier other than Life Medical is able to deliver the product in the impending agreement period, and that the situation that has occurred is not the contracting authorities' fault, nor something that the contracting authorities could predict. SHI therefore believes that there are grounds to make the procurement without an invitation to tender. See the public procurement regulations §21-5, c.f. § 21-2, c.f. § 13-4 letter b no. 3 and letter cf. also § 13-3 letter e.


Winner: Life Medical ApS
Award value: 12180600